Literature DB >> 7950347

Clozapine-induced seizures and EEG changes.

J Welch1, T Manschreck, D Redmond.   

Abstract

Clozapine, an atypical antipsychotic drug, is widely used in refractory schizophrenia. At New Hampshire Hospital, 7 of the first 35 patients treated (20%) had convulsions. Patterns were tonic-clonic (5), complex partial (2), and myoclonic (3). Seizures were dose-related and may be anticholinergic in etiology. EEG changes are frequent with clozapine, particularly as dosage is increased. Twenty-six of 35 patients (74%) had EEG abnormalities at some time during clozapine treatment. EEG is a sensitive means of detecting clinical toxicity. When EEG abnormalities (slowing, dysrhythmia, or paroxysmal discharges) are detected, immediately lowering the dose by at least 25-50 mg per day and adjusting weekly until EEG returns to baseline can reduce the incidence of seizures.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7950347     DOI: 10.1176/jnp.6.3.250

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  14 in total

1.  EEG Abnormalities in a patient taking Aripiprazole.

Authors:  Monica Arora; Laurie Arndorfer
Journal:  Psychiatry (Edgmont)       Date:  2007-07

Review 2.  Effects of psychotropic drugs on seizure threshold.

Authors:  Francesco Pisani; Giancarla Oteri; Cinzia Costa; Giorgio Di Raimondo; Raoul Di Perri
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 3.  Seizure associated with clozapine: incidence, etiology, and management.

Authors:  Andrew M Williams; Susie H Park
Journal:  CNS Drugs       Date:  2015-02       Impact factor: 5.749

4.  Diffuse electroencephalogram slowing in psychiatric patients: a preliminary report.

Authors:  N N Boutros
Journal:  J Psychiatry Neurosci       Date:  1996-07       Impact factor: 6.186

5.  Rapid liquid chromatography/tandem mass spectrometer (LCMS) method for clozapine and its metabolite N-desmethyl clozapine (norclozapine) in human serum.

Authors:  L V Rao; M L Snyder; G M Vallaro
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

6.  Clozapine-related EEG changes and seizures: dose and plasma-level relationships.

Authors:  Seema Varma; Delia Bishara; Frank M C Besag; David Taylor
Journal:  Ther Adv Psychopharmacol       Date:  2011-04

Review 7.  Clozapine-induced myoclonus: a case report and review of the literature.

Authors:  Ian J Osborne; Ronan J McIvor
Journal:  Ther Adv Psychopharmacol       Date:  2015-12

8.  Electroencephalographic abnormalities in clozapine-treated patients: a cross-sectional study.

Authors:  Nishant Goyal; Samir Kumar Praharaj; Pushpal Desarkar; Haque Nizamie
Journal:  Psychiatry Investig       Date:  2011-12-08       Impact factor: 2.505

9.  EEG alterations during treatment with olanzapine.

Authors:  Detlef Degner; Michael A Nitsche; Frank Bias; Eckart Rüther; Udo Reulbach
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-03-23       Impact factor: 5.270

10.  Clozapine-induced seizures, electroencephalography abnormalities, and clinical responses in Japanese patients with schizophrenia.

Authors:  Yuka Sugawara Kikuchi; Wataru Sato; Keiichiro Ataka; Kiwamu Yagisawa; Yuki Omori; Takashi Kanbayashi; Tetsuo Shimizu
Journal:  Neuropsychiatr Dis Treat       Date:  2014-10-15       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.